Transgenic non-human mammals with an oncogene under the control of an inducible liver-specific promoter
CA 2105594 A1 · Owner: Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. · Inventors: Ciliberto, Gennaro
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
i -, TRANSGENIC NON-HUMAN MAMMALS WITH AN ONCOGENE UNDER THE CONTROL OF AN INDUCIBLE LIVER-SPECIFIC PROMOTER ABSTRACT, A transgenic non-human mammal characterized in, that all its germ cells and somatic cells contain a recombinant activated oncogene - under the control of an inducible liver specific promoter - introduced into said mammal, or an ancestor of said mammal at an, embryonic stage of its development. Extremely satisfactory results were obtained when the oncogenic sequence comprises the sequence coding for the big Tantigen of SV 40 virus and when the inducible liver specific promoter controlling the oncoqene is the promoter of the human gene coding for C-reactive protein. The …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 7, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 7, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 7, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.